A growing field  Face transplants remain unique and require very specific criteria such as hairlines and ethnic components, explains a UNOS spokesperson  Richard Luskin, CEO of the New England Organ Bank Face transplant patients: Where are they now? Risk of rejection  These (face transplant) patients are not in organ failure but are having to take anti-rejection medication and have lifelong repression, explains Dr  We need new therapies which will be less harmful, she says By combining the two cells and delivering them into patients receiving a transplant, their immune system will learn to recognize the donor's cells, which are present throughout their new face, making their immune cells less likely to attack the face Luskin feels the benefits of a new face counter ethical doubts Face transplant recipients: New findings 